ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis (TICE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00864318
Recruitment Status : Active, not recruiting
First Posted : March 18, 2009
Last Update Posted : March 2, 2018
Sponsor:
Information provided by (Responsible Party):
Institut Claudius Regaud

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : September 2021
  Estimated Study Completion Date : September 2029